Rachel Würstlein
Hat mitgewirkt an:
-
Kadcyla : neuer Standard für die Zweitlinientherapie des HER2-positiven metastasierten Mammakarzinoms
-
Manual Mammakarzinom
-
Update breast cancer 2023 Part 3 – expert opinions of early stage breast cancer therapies
-
Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial